Novo Nordisk A/S (NYSE:NVO)
| 61.31 Delayed Data As of Jan 17 |  0.00 / 0.00%Today’s Change | 46.10 Today|||52-Week Range 62.69 | +5.93% Year-to-Date |
Latest NVO News | Press Releases
No recent news for Novo Nordisk A/S.
Today’s Trading
| Previous close | 61.31 |
| Today’s open | 61.46 |
| Day’s range | 61.22 - 61.54 |
| Volume | 1,253,391 |
| Average volume (3 months) | 1,430,065 |
| Market cap | $110.8B |
Data as of 6:30pm ET, 01/17/2020
Growth & Valuation
| Earnings growth (last year) | +8.07% |
| Earnings growth (this year) | +0.22% |
| Earnings growth (next 5 years) | +9.65% |
| Revenue growth (last year) | +4.51% |
| P/E ratio | 25.5 |
| Price/Sales | 6.31 |
| Price/Book | 18.48 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| GSKGlaxoSmithKline | +0.73 | +1.55% |
| SNYSanofi | +0.05 | +0.10% |
| ABBVAbbVie | -1.26 | -1.41% |
| LLYEli Lilly and Co | -1.85 | -1.31% |
Data as of 6:30pm ET, 01/17/2020
Financials
| Next reporting date | February 5, 2020 |
| EPS forecast (this quarter) | $0.57 |
| Annual revenue (last year) | $17.7B |
| Annual profit (last year) | $6.1B |
| Net profit margin | 34.54% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Bagsværd, Capital Region |
Forecasts
